NCT04577313 HIV Treatment Adherence Dose Determination Trial
| NCT ID | NCT04577313 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Connecticut |
| Condition | HIV Infections |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2020-09-01 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2020-09-01 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Eligibility Criteria
Inclusion Criteria: * Confirmed HIV positive * Confirmed prescribed antiretroviral therapy * Confirmed non-adherent to anti-retroviral therapy Exclusion Criteria: * Does not have access to a phone * Does not have access to the internet
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04577313 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04577313 currently recruiting?
Yes, NCT04577313 is actively recruiting participants. Contact the research team at seth.k@uconn.edu for enrollment information.
Where is the NCT04577313 trial being conducted?
This trial is being conducted at Storrs, United States, Atlanta, United States.
Who is sponsoring the NCT04577313 clinical trial?
NCT04577313 is sponsored by University of Connecticut. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.